The American Heart Association filed a lawsuit against the Food and Drug Administration challenging relaxed standards on fruit-flavored vaping products

Overview Debates Related claims Topics

Meta, Google, and TikTok filed separate federal lawsuits in San Francisco, San Jose, and Los Angeles challenging California Assembly Bill 1709

Under Attorney General Ken Paxton, the Texas Attorney General's office filed legal challenges against DACA and the sale of mifepristone

An Environmental Protection Agency assessment on glyphosate safety was discarded in court after evidence showed chemical company Bayer ghostwrote research sections

Department of Justice attorney Sarah Harris, previously employed at Bayer's primary law firm, drafted the brief supporting glyphosate liability protection before the Supreme Court

The Food and Drug Administration Center for Biologics Evaluation and Research vaccine division was led by a former head of vaccine development at Merck

The federal standard for 7-hydroxymitragynine in kratom products was initially recommended at a concentration cap of 0.05 percent

Food and Drug Administration Commissioner Marty Makary was dismissed from office after resisting efforts to ease approval standards for fruit-flavored e-cigarettes

The concentration allowance for the opioid alkaloid 7-hydroxymitragynine in retail kratom products was raised twentyfold above initial recommendations

Federal regulations require safety studies demonstrating a lack of harm to minors prior to Food and Drug Administration approval of vaping products

The United States Department of Health and Human Services compounding peptide policy includes requirements regarding registered manufacturing facilities, certificates of analysis, and labeling

The United States Department of Health and Human Services announced an enforcement policy covering six peptides: BPC-157, Epitalon, KPV, MOTS-c, Semax, and TB-500

The United States Department of Health and Human Services compounding peptide policy restricts the combination of multiple active peptides into a single compounded product

Under specific conditions, the United States Department of Health and Human Services does not intend to take enforcement action against certain peptide compounders while an FDA formal evaluation process continues

The ICON study published in the journal Chest demonstrated a greater than 50% reduction in mortality among hospitalized COVID-19 patients treated with ivermectin

The Federal Trade Commission sued Nate Jones and Xlear Corporation over marketing and studies of nasal sprays and gargles against SARS-CoV-2

The Federal Trade Commission took regulatory action against Dr. Eric Nepute regarding clinical claims about vitamin D and COVID-19

In 2021, the American Medical Association issued an official policy statement calling for the cessation of ivermectin prescriptions for COVID-19

Drs. Paul Marik, Robert Apter, and Mary Talley Bowden filed a federal lawsuit against the United States Food and Drug Administration regarding its public statements on ivermectin

The World Health Organization and the European Society of Intensive Care Medicine issued recommendations in November 2020 advising against the use of remdesivir for COVID-19

In November 2020, Dr. Peter McCullough published the multi-drug outpatient COVID-19 treatment protocol in the American Journal of Medicine